GlaxoSmithKline Bangladesh Limited announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was BDT 1,087.414 million compared to BDT 1,144.988 million a year ago. Operating income was BDT 172.956 million compared to BDT 138.176 million a year ago. Net income was BDT 134.808 million compared to BDT 43.970 million a year ago. Basic earnings per share from continuing operations was BDT 12.76 compared to BDT 10.59 a year ago. Basic earnings per share was BDT 11.19 compared to BDT 3.65 a year ago. For the half year, sales was BDT 2,316.982 million compared to BDT 2,334.016 million a year ago. Operating income was BDT 390.630 million compared to BDT 312.726 million a year ago. Net income was BDT 268.047 million compared to BDT 182.392 million a year ago. Basic earnings per share from continuing operations was BDT 28.53 compared to BDT 22.41 a year ago. Basic earnings per share was BDT 22.25 compared to BDT 15.14 a year ago.